All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| HTGM / HTG Molecular Diagnostics Inc
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
| KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| 09074D103 / Biotie Therapies Corp.
|
|
|
|
|
|
|
|
| ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| EPRSQ / Epirus Biopharmaceuticals Inc
|
|
|
|
|
|
|
|
| CYAD / Celyad Oncology - ADR
|
|
|
|
|
|
|
|
| GEVA / Synageva Biopharma Corp
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
| GALT / Galectin Therapeutics Inc.
|
|
|
|
|
|
|
|
| GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
| NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
| PVCT / Provectus Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US7170711045 / Pfenex Inc.
|
|
|
|
|
|
|
|
| CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
| AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
| KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
| ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| 88165UAB5 / TetraLogic Pharmaceuticals Corporation Bond
|
|
|
|
|
|
|
|
| AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PVCT / Provectus Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RMTI / Rockwell Medical, Inc.
|
|
|
|
|
|
|
|
| RCPT / Receptos, Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| 17K / Self Storage Group ASA
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| ACRX / Talphera, Inc.
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| DARE / Daré Bioscience, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| CBPO / China Biologic Products Holdings Inc
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 15117F112 / Cellectar Biosciences, Inc. Series A Warrants
|
|
|
|
|
|
|
|
| CLTX / Celsus Therapeutics
|
|
|
|
|
|
|
|
| MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
| AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
